The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $5.42 in the prior trading day, CorMedix Inc (NASDAQ: CRMD) closed at $5.28, down -2.58%. In other words, the price has decreased by -$2.58 from its previous closing price. On the day, 1.99 million shares were traded. CRMD stock price reached its highest trading level at $6.22 during the session, while it also had its lowest trading level at $5.13.
Ratios:
Our goal is to gain a better understanding of CRMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.78 and its Current Ratio is at 6.97. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on August 10, 2023, initiated with a Outperform rating and assigned the stock a target price of $6.
On February 17, 2021, Needham started tracking the stock assigning a Buy rating and target price of $31.
On September 29, 2020, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $22.JMP Securities initiated its Mkt Outperform rating on September 29, 2020, with a $22 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 13 ’24 when Todisco Joseph bought 13,561 shares for $3.74 per share. The transaction valued at 50,718 led to the insider holds 352,839 shares of the business.
DUNTON ALAN W bought 3,000 shares of CRMD for $9,900 on Dec 15 ’23. The Director now owns 15,250 shares after completing the transaction at $3.30 per share. On Dec 14 ’23, another insider, DUNTON ALAN W, who serves as the Director of the company, bought 3,000 shares for $3.45 each. As a result, the insider paid 10,350 and bolstered with 12,250 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 290300224 and an Enterprise Value of 214937216.
Stock Price History:
The Beta on a monthly basis for CRMD is 1.76, which has changed by 0.08418894 over the last 52 weeks, in comparison to a change of 0.2006725 over the same period for the S&P500. Over the past 52 weeks, CRMD has reached a high of $7.00, while it has fallen to a 52-week low of $2.57. The 50-Day Moving Average of the stock is 32.80%, while the 200-Day Moving Average is calculated to be 41.71%.
Shares Statistics:
The stock has traded on average 586.88K shares per day over the past 3-months and 1312170 shares per day over the last 10 days, according to various share statistics. A total of 54.94M shares are outstanding, with a floating share count of 53.86M. Insiders hold about 2.03% of the company’s shares, while institutions hold 33.77% stake in the company. Shares short for CRMD as of 1711584000 were 8245045 with a Short Ratio of 14.05, compared to 1709164800 on 7718901. Therefore, it implies a Short% of Shares Outstanding of 8245045 and a Short% of Float of 15.0.
